Series C Biotechnology Companies

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

Intelligence to Accelerate Human Health

Automata is a lab automation company offering the LINQ platform to streamline workflows and boost laboratory efficiency.

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

Florence is a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.

Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.

Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.

Memo Therapeutics is a biotechnology research company that engages in antibody discovery and immune repertoire analysis.

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

AgroDesign Studio is a biotechnology firm specializing in the research and development of molecular-targeted pesticides

ByHeart is a baby nutrition company with FDA-registered infant formula.

Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

Covercress is a biotechnology company that manufactures an oilseed crop for food, bioenergy, and cattle feed.

Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.

Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.

Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.